60d published FRN

56458

Federal Register / Vol. 76, No. 177 / Tuesday, September 13, 2011 / Notices

The purpose of this analysis is to
facilitate public comment on the
Consent Agreement, and it is not
intended to constitute an official
interpretation of the proposed Decision
and Order or the Order to Maintain
Assets, or to modify their terms in any
way.
By direction of the Commission.
Donald S. Clark
Secretary.
[FR Doc. 2011–23305 Filed 9–12–11; 8:45 am]
BILLING CODE 6750–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Assistant Secretary for
Planning and Evaluation; Meeting of
the Advisory Council on Alzheimer’s
Research, Care, and Services

mstockstill on DSK4VPTVN1PROD with NOTICES

SUMMARY: This notice announces public
meetings of the Advisory Council on
Alzheimer’s Research, Care, and
Services (Advisory Council). Notice of
these meetings is given under the
Federal Advisory Committee Act (5
U.S.C. App. 2, section 10(a)(1) and
(a)(2)). The Advisory Council on
Alzheimer’s Research, Care, and
Services will provide advice on how to
prevent or reduce the burden of
Alzheimer’s disease and related
dementias on people with the disease
and their caregivers. Representatives
from the Department of Health and
Human Services (HHS) will present
inventories of Federal activities related
to Alzheimer’s disease and related
dementias in three areas: research,
clinical care, and long-term services and
support. The representatives will also
identify gaps and opportunities in these
areas. The Advisory Council will
discuss the inventories, gaps, and
opportunities, and make
recommendations to the Secretary for
priority areas and actions for a national
plan to address Alzheimer’s disease and
related dementias.
Meeting Date: September 27, 2011,
9:30 a.m. to 4 p.m.
ADDRESSES: The meeting will be held at
Administration on Aging headquarters
at 1 Massachusetts Ave., NW.,
Washington, DC, 20001, Room 5604/
5403.
Comments: Time is allocated on the
agenda to hear public comments at the
end of the meeting. In lieu of oral
comments, formal written comments
may be submitted for the record to

19:22 Sep 12, 2011

Jkt 223001

FOR FURTHER INFORMATION CONTACT:

Helen Lamont (202) 690–7996,
[email protected] Note: Although
the meeting is open to the public,
procedures governing security and the
entrance to Federal buildings may
change without notice. Those wishing to
attend the meeting must call or e-mail
Dr. Lamont by Thursday September 22,
2011, so that their name may be put on
a list of expected attendees and
forwarded to the security officers at the
Administration on Aging. Space is
limited to 40 participants.
Topics of
the Meeting: The Advisory Council will
hear presentations and provide feedback
on inventories of Federal activities to
address Alzheimer’s disease and related
dementias, gaps that can be addressed,
and opportunities for collaboration. The
Advisory Council is specifically charged
with discussing and making
recommendations to the Secretary on
priorities for a national plan to address
Alzheimer’s disease and related
dementias.
Procedure and Agenda: This meeting
is open to the public. Representatives of
HHS will present the inventories of
Federal activities related to Alzheimer’s
disease and related dementias to the
Advisory Council. The representatives
will also identify gaps and opportunities
in these areas. After each presentation,
the Advisory Council will openly
discuss the inventory and the findings.
Interested persons may observe the
discussion, but the Advisory Council
will not hear public comments during
this time. The Advisory Council will
allow an open public session for any
attendee to address issues specific to the
inventories or topics that should be
addressed by a national plan.

SUPPLEMENTARY INFORMATION:

Assistant Secretary for
Planning and Evaluation, HHS.
ACTION: Notice of meeting.
AGENCY:

VerDate Mar<15>2010

Helen Lamont, OASPE, 200
Independence Ave., SW., Washington,
DC 20201, Room 424E. Those
submitting written comments should
identify themselves and any relevant
organizational affiliations.

Authority: 42 U.S.C. 11225; Section 2(e)(3)
of the National Alzheimer’s Project Act. The
panel is governed by provisions of Public
Law 92–463, as amended (5 U.S.C. Appendix
2), which sets forth standards for the
formation and use of advisory committees.
Dated: September 8, 2011.
Sherry Glied,
Assistant Secretary for Planning and
Evaluation.
[FR Doc. 2011–23465 Filed 9–9–11; 11:15 am]
BILLING CODE 4150–05–P

PO 00000

Frm 00067

Fmt 4703

Sfmt 4703

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–11–0666]

Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Daniel Holcomb, CDC
Reports Clearance Officer, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an e-mail to [email protected].
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Healthcare Safety Network
(NHSN) (OMB No. 0920–0666) exp. 05/
31/2014—Revision—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The National Healthcare Safety
Network (NHSN) is a system designed to
accumulate, exchange, and integrate
relevant information and resources
among private and public stakeholders
to support local and national efforts to
protect patients and promote healthcare
safety. Specifically, the data is used to
determine the magnitude of various
healthcare-associated adverse events
and trends in the rates of these events
among patients and healthcare workers
with similar risks. The data will be used
to detect changes in the epidemiology of

E:\FR\FM\13SEN1.SGM

13SEN1

56459

Federal Register / Vol. 76, No. 177 / Tuesday, September 13, 2011 / Notices
adverse events resulting from new and
current medical therapies and changing
risks. The NHSN previously consisted of
four components: Patient Safety,
Healthcare Personnel Safety,
Biovigilance, and eSurveillance. In
addition, a fifth component, Long Term
Care Facilities (LTCF) is included in
this revision. In general, the data
reported under the Patient Safety
Component protocols are used to (1)
determine the magnitude of the
healthcare-associated adverse events
under study, trends in the rates of
events, in the distribution of pathogens,
and in the adherence to prevention
practices, and (2) to detect changes in
the epidemiology of adverse events
resulting from new medical therapies
and changing patient risks.
Additionally, reported data will be used
to describe the epidemiology of
antimicrobial use and resistance and to
understand the relationship of
antimicrobial therapy to this growing
problem. Under the Healthcare
Personnel Safety Component protocols,
data on events—both positive and
adverse—are used to determine (1) the
magnitude of adverse events in
healthcare personnel and (2)
compliance with immunization and
sharps injuries safety guidelines. Under
the Biovigilance Component, data on
adverse reactions and incidents
associated with blood transfusions are

A CMS ruling states that these specific
hospital types must begin reporting HAI
surveillance. Therefore, in order to
accurately capture data relevant to those
specific facility types, separate annual
facility surveys were created. Also
within the Patient Safety Component, a
new form will be added, Streamlined
Ventilator-Associated Pneumonia, to
provide a streamlined, objective
definition via which NHSN users may
detect and report cases of ventilatorassociated pneumonia in adult patients
only. Finally there are many updates,
clarifications, and data collection
revisions proposed in this submission.
The previously approved NSHN
package included 48 individual
collection forms; the current revision
request includes six new forms for a
total of 54 forms. The reporting burden
will increase by 64,050 hours, for a total
of 3,978,175 hours.
Healthcare institutions that
participate in NHSN voluntarily report
their data to CDC using a Web browser
based technology for data entry and data
management. Data are collected by
trained surveillance personnel using
written standardized protocols.
Participating institutions must have a
computer capable of supporting an
Internet service provider (ISP) and
access to an ISP. There is no cost to
respondents other than their time.

used to provide national estimates of
adverse reactions and incidents. The
Long-Term Care Facility (LTCF)
Component will be used to more
specifically and appropriately capture
data from the residents of skilled
nursing facilities. In order to facilitate
this reporting, seven LTCF forms were
created by using forms from the Patient
Safety Component as a base, with
modifications to specifically address the
nuances of LTC residents.
This revision submission includes the
remaining three LTCF Component forms
needed to facilitate healthcareassociated infection (HAI) surveillance
in this setting, for which no
standardized reporting methodology or
mechanism currently exists. The three
submitted LTCF forms along with the
four previously approved LTCF forms
will complete the LTCF Component.
The scope of NHSN dialysis
surveillance is being expanded to
include all outpatient dialysis centers,
so that the existing Dialysis Annual
Survey can be used to facilitate
prevention objectives set forth in the
HHS HAI tier 2 Action Plan and to
assess national practices in all
Medicare-certified dialysis centers if
CMS re-establishes this survey method
(as expected). In addition, two new
annual facility surveys will be added for
Long-term Acute Care Hospitals (LTAC)
and Rehabilitation Hospitals (REHAB).

ESTIMATE OF ANNUALIZED BURDEN HOURS
Form number and name
57.100: NHSN Registration Form .....
57.101: Facility Contact Information
57.103: Patient Safety Component—
Annual Facility Survey.
57.104: Patient Safety Component—
Outpatient Dialysis Center Practices Survey.
57.105: Group Contact Information ...

mstockstill on DSK4VPTVN1PROD with NOTICES

57.106: Patient Safety Monthly Reporting Plan.
57.108: Primary Bloodstream Infection (BSI).
57.109: Dialysis Event .......................
57.111: Pneumonia (PNEU) ..............
57.112: Streamlined Ventilator-Associated Pneumonia.
57.114: Urinary Tract Infection (UTI)
57.116: Denominators for Neonatal
Intensive Care Unit (NICU).
57.117: Denominators for Specialty
Care Area (SCA).
57.118: Denominators for Intensive
Care Unit (ICU)/Other locations
(not NICU or SCA).

VerDate Mar<15>2010

19:22 Sep 12, 2011

Number of
respondents

Type of respondents
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).

Number of
responses per
respondent

Avg. burden
per response
(in hours)

Total burden
(in hours)

(Infection

6,000

1

5/60

500

(Infection

6,000

1

10/60

1,000

(Infection

6,000

1

30/60

3,000

(Infection

5,500

1

1

5,500

Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Staff RN ...........................................
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Staff RN ...........................................

6,000

1

5/60

500

6,000

9

35/60

31,500

6,000

36

33/60

118,800

5,500
6,000

75
72

16/60
32/60

110,000
230,400

6,000

144

25/60

360,000

6,000

27

32/60

86,400

6,000

9

3

162,000

Staff RN ...........................................

6,000

9

5

270,000

Staff RN ...........................................

6,000

18

5

540,000

Jkt 223001

PO 00000

Frm 00068

Fmt 4703

Sfmt 4703

E:\FR\FM\13SEN1.SGM

13SEN1

56460

Federal Register / Vol. 76, No. 177 / Tuesday, September 13, 2011 / Notices
ESTIMATE OF ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
respondent

Avg. burden
per response
(in hours)

Total burden
(in hours)

Type of respondents

57.119: Denominator for Outpatient
Dialysis.
57.120: Surgical Site Infection (SSI)

Staff RN ...........................................

5,500

12

6/60

6,600

Registered
Nurse
(Infection
Preventionist).
Staff RN ...........................................
Laboratory Technician .....................

6,000

36

32/60

115,200

6,000
6,000

540
12

8/60
5/60

432,000
6,000

Pharmacy Technician ......................

6,000

12

5/60

6,000

Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).

(Infection

1,000

100

5/60

8,333

(Infection

6,000

72

32/60

230,400

(Infection

6,000

24

10/60

24,000

Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).
Registered
Nurse
Preventionist).

(Infection

6,000

240

15/60

360,000

(Infection

6,000

5

14

420,000

(Infection

2,000

5

2

20,000

(Infection

2,000

250

10/60

83,333

(Infection

250

1

25/60

104

(Infection

250

8

15/60

500

(Infection

250

3

5/60

63

Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Registered
Nurse
(Infection
Preventionist).
Occupational Health RN/Specialist ..

250

9

30/60

1,125

250

12

5/60

250

250

12

3

9,000

250

12

5/60

250

400

1

30/60

200

1,000

1

25/60

417

6,000

1

8

48,000

Occupational Health RN/Specialist ..
Occupational Health RN/Specialist ..

600
600

100
9

10/60
10/60

10,000
900

Occupational Health RN/Specialist ..

600

200

20/60

40,000

Occupational Health RN/Specialist ..

600

50

1

30,000

Occupational Health RN/Specialist ..

600

10

15/60

1,500

Laboratory Technician .....................

600

100

15/60

15,000

Occupational Health RN/Specialist ..

600

300

10/60

30,000

Occupational Health RN/Specialist ..

600

500

10/60

50,000

Occupational Health RN/Specialist ..

600

50

10/60

5,000

Occupational Health RN/Specialist ..

600

1

10/60

100

57.121: Denominator for Procedure ..
57.123: Antimicrobial Use and Resistance
(AUR)—Microbiology
Data Electronic Upload Specification Tables.
57.124: Antimicrobial Use and Resistance (AUR)—Pharmacy Data
Electronic Upload Specification Tables.
57.125: Central Line Insertion Practices Adherence Monitoring.
57.126: MDRO or CDI Infection Form
57.127: MDRO and CDI Prevention
Process and Outcome Measures
Monthly Monitoring.
57.128: Laboratory-identified MDRO
or CDI Event.
57.130: Vaccination Monthly Monitoring Form—Summary Method.
57.131: Vaccination Monthly Monitoring Form—Patient-Level Method.
57.133: Patient Vaccination ..............
57.137: Patient Safety Component—
Annual Facility Survey for LTCF.
57.138: Laboratory-identified MDRO
or CDI Event for LTCF.
57.139: MDRO and CDI Prevention
Process Measures Monthly Monitoring for LTCF.
57.140: Urinary Tract Infection (UTI)
for LTCF.
57.141: Monthly Reporting Plan for
LTCF.
57.142: Denominators for LTCF Locations.
57.143: Prevention Process Measures Monthly Monitoring for LTCF.
57.150: LTAC Annual Survey ...........
57.151: Rehab Annual Survey ..........

mstockstill on DSK4VPTVN1PROD with NOTICES

Number of
respondents

Form number and name

57.200: Healthcare Personnel Safety
Component Annual Facility Survey.
57.202: Healthcare Worker Survey ...
57.203: Healthcare Personnel Safety
Monthly Reporting Plan.
57.204: Healthcare Worker Demographic Data.
57.205: Exposure to Blood/Body
Fluids.
57.206: Healthcare Worker Prophylaxis/Treatment.
57.207: Follow-Up Laboratory Testing.
57.208: Healthcare Worker Vaccination History.
57.209: Healthcare Worker Influenza
Vaccination.
57.210: Healthcare Worker Prophylaxis/Treatment—Influenza.
57.211: Pre-season Survey on Influenza Vaccination Programs for
Healthcare Personnel.

VerDate Mar<15>2010

19:22 Sep 12, 2011

Jkt 223001

PO 00000

Frm 00069

Fmt 4703

Sfmt 4703

E:\FR\FM\13SEN1.SGM

13SEN1

56461

Federal Register / Vol. 76, No. 177 / Tuesday, September 13, 2011 / Notices
ESTIMATE OF ANNUALIZED BURDEN HOURS—Continued
Number of
respondents

Number of
responses per
respondent

Avg. burden
per response
(in hours)

Total burden
(in hours)

Form number and name

Type of respondents

57.212: Post-season Survey on Influenza Vaccination Programs for
Healthcare Personnel.
57.213: Healthcare Personnel Influenza Vaccination Monthly Summary.
57.300: Hemovigilance Module Annual Survey.
57.301:
Hemovigilance
Module
Monthly Reporting Plan.
57.302:
Hemovigilance
Module
Monthly Incident Summary.
57.303:
Hemovigilance
Module
Monthly Reporting Denominators.
57.304: Hemovigilance Adverse Reaction.
57.305: Hemovigilance Incident ........

Occupational Health RN/Specialist ..

600

1

10/60

100

Occupational Health RN/Specialist ..

6,000

6

2

72,000

Medical/Clinical
nologist.
Medical/Clinical
nologist.
Medical/Clinical
nologist.
Medical/Clinical
nologist.
Medical/Clinical
nologist.
Medical/Clinical
nologist.

Total Est Annual Burden Hours:
3,978,175
Dated: September 6, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2011–23302 Filed 9–12–11; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Emerging Infections Programs,
Funding Opportunity Announcement
(FOA), CK12–1202, initial review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
Time and Date: 8 a.m.–5 p.m., November
9, 2011 (Closed).

Laboratory

Tech-

500

1

2

1,000

Laboratory

Tech-

500

12

2/60

200

Laboratory

Tech-

500

12

2

12,000

Laboratory

Tech-

500

12

30/60

3,000

Laboratory

Tech-

500

120

10/60

10,000

Laboratory

Tech-

500

72

10/60

6,000

Place: Holiday Inn Decatur Conference
Plaza, 130 Clairemont Avenue, Decatur,
Georgia 30030, Telephone: (404) 371–0204.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Emerging Infections Programs,
FOA CK12–1202.’’
Contact Person for More Information: Amy
Yang, Ph.D., Scientific Review Officer, CDC,
1600 Clifton Road, NE., Mailstop E60,
Atlanta, Georgia 30333, Telephone: (404)
498–2733.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: August 31, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–23300 Filed 9–12–11; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Family Violence Prevention and
Services: Grants to States; Native
American Tribes and Alaskan Native
Villages; and State Domestic Violence
Coalitions.
OMB No.: 0970–0280.
Description: The Family Violence
Prevention and Services Act (FVPSA),
42 U.S.C. 10401 et seq., authorizes the
Department of Health and Human
Services to award grants to States,
Territories, Tribes or Tribal
Organizations, and State Domestic
Violence Coalitions for family violence
prevention and intervention activities.
The proposed information collection
activities will be used to make grant
award decisions and to monitor grant
performance.
Respondents: State Agencies and
Territories Administering FVPSA
Grants; Tribal Governments and Tribal
Organizations; and State Domestic
Violence Coalitions.

mstockstill on DSK4VPTVN1PROD with NOTICES

ANNUAL BURDEN ESTIMATES
Number of
respondents

Instrument
State Grant Application ....................................................................................
Tribal Grant Application ...................................................................................
State Domestic Violence Coalition Application ................................................
State and Territory FVPSA Grant Performance Progress Report ..................
Tribal FVPSA Grant Performance Progress Report ........................................

VerDate Mar<15>2010

19:22 Sep 12, 2011

Jkt 223001

PO 00000

Frm 00070

Fmt 4703

Sfmt 4703

Number of
responses per
respondent

53
200
56
57
200

E:\FR\FM\13SEN1.SGM

1
1
1
1
1

13SEN1

Average
burden hours
per response
10
5
10
10
15

Total burden
hours
530
1,000
560
570
3,000